How Does the Serrated Polyp Pathway Alter CRC Screening and Surveillance?

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Screening and surveillance for colorectal cancer (CRC) reduces mortality through the detection of early-stage adenocarcinoma, and more importantly the detection and removal of premalignant polyps. While adenomas have historically been considered the most common and screening-relevant precursor lesions, there is accumulating evidence showing that the serrated pathway is an important contributor to CRC, and a disproportionate contributor to interval or postcolonoscopy CRC, particularly in the proximal colon. The serrated pathway is characterized by mutations in the BRAF gene, high levels of methylation of promoter CpG islands (CIMP-high), and the sessile serrated adenoma/polyp (SSA/P) is the most important precursor lesion. The study of serrated polyps has been complicated by evolving nomenclature, substantial variation among pathologists in the identification of SSA/Ps, high variability in endoscopic detection rates, and uncertainty regarding the relation to synchronous and metachronous colonic neoplasia. This paper presents an overview of the serrated polyp pathway and discusses its clinical implications including its impact on CRC screening.

Original languageEnglish
Pages (from-to)773-780
Number of pages8
JournalDigestive Diseases and Sciences
Volume60
Issue number3
DOIs
StatePublished - Mar 1 2015

Fingerprint

Polyps
Early Detection of Cancer
Colorectal Neoplasms
Adenoma
CpG Islands
Terminology
Methylation
Uncertainty
Colon
Adenocarcinoma
Mutation
Mortality
Genes
Neoplasms

Keywords

  • Colon cancer
  • Colorectal neoplasms
  • Screening
  • Serrated polyps

ASJC Scopus subject areas

  • Gastroenterology
  • Physiology
  • Medicine(all)

Cite this

How Does the Serrated Polyp Pathway Alter CRC Screening and Surveillance? / Kahi, Charles.

In: Digestive Diseases and Sciences, Vol. 60, No. 3, 01.03.2015, p. 773-780.

Research output: Contribution to journalArticle

@article{e4a06a8bc9ee4ad795d10d803a45862e,
title = "How Does the Serrated Polyp Pathway Alter CRC Screening and Surveillance?",
abstract = "Screening and surveillance for colorectal cancer (CRC) reduces mortality through the detection of early-stage adenocarcinoma, and more importantly the detection and removal of premalignant polyps. While adenomas have historically been considered the most common and screening-relevant precursor lesions, there is accumulating evidence showing that the serrated pathway is an important contributor to CRC, and a disproportionate contributor to interval or postcolonoscopy CRC, particularly in the proximal colon. The serrated pathway is characterized by mutations in the BRAF gene, high levels of methylation of promoter CpG islands (CIMP-high), and the sessile serrated adenoma/polyp (SSA/P) is the most important precursor lesion. The study of serrated polyps has been complicated by evolving nomenclature, substantial variation among pathologists in the identification of SSA/Ps, high variability in endoscopic detection rates, and uncertainty regarding the relation to synchronous and metachronous colonic neoplasia. This paper presents an overview of the serrated polyp pathway and discusses its clinical implications including its impact on CRC screening.",
keywords = "Colon cancer, Colorectal neoplasms, Screening, Serrated polyps",
author = "Charles Kahi",
year = "2015",
month = "3",
day = "1",
doi = "10.1007/s10620-014-3449-z",
language = "English",
volume = "60",
pages = "773--780",
journal = "Digestive Diseases and Sciences",
issn = "0163-2116",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - How Does the Serrated Polyp Pathway Alter CRC Screening and Surveillance?

AU - Kahi, Charles

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Screening and surveillance for colorectal cancer (CRC) reduces mortality through the detection of early-stage adenocarcinoma, and more importantly the detection and removal of premalignant polyps. While adenomas have historically been considered the most common and screening-relevant precursor lesions, there is accumulating evidence showing that the serrated pathway is an important contributor to CRC, and a disproportionate contributor to interval or postcolonoscopy CRC, particularly in the proximal colon. The serrated pathway is characterized by mutations in the BRAF gene, high levels of methylation of promoter CpG islands (CIMP-high), and the sessile serrated adenoma/polyp (SSA/P) is the most important precursor lesion. The study of serrated polyps has been complicated by evolving nomenclature, substantial variation among pathologists in the identification of SSA/Ps, high variability in endoscopic detection rates, and uncertainty regarding the relation to synchronous and metachronous colonic neoplasia. This paper presents an overview of the serrated polyp pathway and discusses its clinical implications including its impact on CRC screening.

AB - Screening and surveillance for colorectal cancer (CRC) reduces mortality through the detection of early-stage adenocarcinoma, and more importantly the detection and removal of premalignant polyps. While adenomas have historically been considered the most common and screening-relevant precursor lesions, there is accumulating evidence showing that the serrated pathway is an important contributor to CRC, and a disproportionate contributor to interval or postcolonoscopy CRC, particularly in the proximal colon. The serrated pathway is characterized by mutations in the BRAF gene, high levels of methylation of promoter CpG islands (CIMP-high), and the sessile serrated adenoma/polyp (SSA/P) is the most important precursor lesion. The study of serrated polyps has been complicated by evolving nomenclature, substantial variation among pathologists in the identification of SSA/Ps, high variability in endoscopic detection rates, and uncertainty regarding the relation to synchronous and metachronous colonic neoplasia. This paper presents an overview of the serrated polyp pathway and discusses its clinical implications including its impact on CRC screening.

KW - Colon cancer

KW - Colorectal neoplasms

KW - Screening

KW - Serrated polyps

UR - http://www.scopus.com/inward/record.url?scp=84930174202&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930174202&partnerID=8YFLogxK

U2 - 10.1007/s10620-014-3449-z

DO - 10.1007/s10620-014-3449-z

M3 - Article

C2 - 25556584

AN - SCOPUS:84930174202

VL - 60

SP - 773

EP - 780

JO - Digestive Diseases and Sciences

JF - Digestive Diseases and Sciences

SN - 0163-2116

IS - 3

ER -